Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AngioDynamics Inc ANGO

Healthcare Medical Devices
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the... see more

Recent & Breaking News (NDAQ:ANGO)

AngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions

Business Wire 2 hours ago

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture

Business Wire April 4, 2024

AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE

Business Wire April 4, 2024

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

Business Wire April 1, 2024

AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024

Business Wire March 19, 2024

AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference

Business Wire March 6, 2024

AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million

Business Wire February 15, 2024

AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease

Business Wire January 23, 2024

AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance

Business Wire January 5, 2024

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

Business Wire December 21, 2023

AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024

Business Wire December 7, 2023

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

Business Wire December 7, 2023

AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance

Business Wire October 4, 2023

AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023

Business Wire September 12, 2023

Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

PR Newswire September 1, 2023

AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation

Business Wire August 15, 2023

AngioDynamics Completes Enrollment for PRESERVE Clinical Study

Business Wire August 3, 2023

AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference

Business Wire July 31, 2023

AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors

Business Wire July 24, 2023

AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance

Business Wire July 12, 2023